The University of Pittsburgh is partnering with a Paris startup company to advance cancer research through the use of artificial intelligence.

Owkin Inc., which was founded in 2016, will partner with Pitt researchers in a three- to six-month pilot study of about 300 patients with a rare form of lung cancer called mesothelioma, which is related to asbestos exposure.

The study is designed to validate earlier Owkin findings that identified a relationship between progression of the disease and the presence of certain molecular signatures in the tumors, said physician Michael Becich, associate vice chancellor for informatics in the health sciences at Pitt, who will lead the Pitt research team.

“This is a very novel setup,” Dr. Becich said. “It’s just a starting point. I care a lot about this area.”

Advertise with us

In the works is an expanded Pitt partnership with Owkin that would include using the company’s pathology tissue slide mining capabilities to study progression of other forms of cancer, including ones of the head and neck and the colon. The company can tap international medical research datasets to better predict drug effectiveness and identify the best drug for individual patients while predicting the patient response to treatment.

Meriem Sefta, Owkin head of partnerships, welcomed the opportunity to work with Pitt researchers.

“We’re thrilled to launch this project with Dr. Becich and his team at Pitt,” Ms. Sefta said in a statement.

In the future, the Pitt partnership with Owkin may make it possible for Pitt to tap into a network of U.S. and European academic medical centers to gain insights from curated patient data captured in clinical trials or research cohorts. The information can shape pharmaceutical drug development studies, identify new biomarkers and better design clinical trials.

Separately, John Gibertson has been named associate director of the newly created Pittsburgh Center for Artificial Intelligence Innovation in Medical Imaging, which recently received a two-year, $400,000 grant from the university. Previously, Dr. Gilbertson was director of pathology informatics at Massachusetts General Hospital. Pitt associate professor Shandong Wu was named director of the medical imaging lab.

Advertise with us

Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699

Updated: 1:54 p.m. March 6, 2020